We are live on ! Find out more
MMED

MiniMed Group Inc

22.50 USD
+0.06
0.27%
At close Updated Sep 11, 4:00 PM EDT
Pre-market
After hours
22.50
0.00
0%
1 day
0.27%
5 days
-5.62%
1 month
13.75%
3 months
45.44%
6 months
24.65%
Year to date
21.69%
1 year
21.69%
5 years
21.69%
10 years
21.69%
 

About: While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.

Employees: 2,800

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 33.3%
Neutral 66.7%
Negative 0%
Positive
The Motley Fool
9 days ago
Why MiniMed Stock Was Soaring This Week
A new product introduction helped lift the top line. It seems there's more where that came from, with new product introductions scheduled over the coming months.
Why MiniMed Stock Was Soaring This Week
Positive
Seeking Alpha
9 days ago
MiniMed Group: Recurring Revenues And Fresh Product Cycle
MiniMed's pumps support the demand for more CGMs and consumables. This creates a recurring revenue base for MMED. MMED's Q1 FY2027 also mentioned newer sensors and a dosing algorithm that should increase its value proposition for customers as well. Their latest quarter was cash flow intensive, but longer-term management expects their cash flow to improve as temporary separation costs roll off.
MiniMed Group: Recurring Revenues And Fresh Product Cycle
Positive
Benzinga
10 days ago
These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results
MiniMed Group Inc (NASDAQ:MMED) on Tuesday reported better-than-expected first-quarter sales results.
These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results
Neutral
Seeking Alpha
11 days ago
MiniMed Group, Inc. (MMED) Q1 2027 Earnings Call Transcript
MiniMed Group, Inc. (MMED) Q1 2027 Earnings Call Transcript
MiniMed Group, Inc. (MMED) Q1 2027 Earnings Call Transcript
Neutral
MarketBeat
11 days ago
MiniMed Group Q1 Earnings Call Highlights
MiniMed Group NASDAQ: MMED reported fiscal 2027 first-quarter revenue of $843 million, with organic revenue growth of 15.8%, as demand for its newer insulin-delivery and continuous glucose monitoring products supported growth in the United States and international markets.
MiniMed Group Q1 Earnings Call Highlights
Neutral
PRNewsWire
11 days ago
MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
Strong start to fiscal year with net sales of $843 million growing 17% as reported and 16% organic U.S. net sales growth accelerated to 13%; continued robust international net sales growth of 18% as reported, 17% organic Advanced global pipeline ahead of schedule with FDA submission for MiniMed Fit™, CE Mark for MiniMed Flex™, Vivera™ FCL U.S. pivotal trial enrollment completion, and IDE approval for next-gen extended wear MiniMed sensor Raises fiscal year 2027 organic revenue growth guidance NORTHRIDGE, Calif., Sept. 1, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today reported financial results for its first quarter (Q1) of fiscal year 2027 (FY27), ended July 31, 2026.
MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
Neutral
Benzinga
15 days ago
Top Wall Street Forecasters Revamp MiniMed Group Expectations Ahead Of Q1 Earnings
MiniMed Group, Inc. (NASDAQ:MMED) will release its first quarter earnings report before the opening bell on Tuesday, Sept. 1.
Top Wall Street Forecasters Revamp MiniMed Group Expectations Ahead Of Q1 Earnings
Neutral
PRNewsWire
18 days ago
MiniMed to Participate in Upcoming Investor Conferences
NORTHRIDGE, Calif., Aug. 25, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that management will participate in fireside chats at the following investor conferences: 21st Annual Wells Fargo Healthcare Conference Tuesday, September 8, 2026, at 3:00 p.m.
MiniMed to Participate in Upcoming Investor Conferences
Neutral
Zacks Investment Research
23 days ago
MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor
MMED's MiniMed Flex is now shipping in the U.S. with Abbott's 15-day Instinct sensor, pairing discreet app control with automated insulin delivery.
MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor
Neutral
PRNewsWire
26 days ago
MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor
MiniMed Flex™ with Instinct, made by Abbott, combines discreet design, up to 15 days of sensor wear and proven automation to reduce the work and interruptions of diabetes management NORTHRIDGE, Calif., Aug. 17, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) today announced that the MiniMed Flex™ system is now commercially shipping in the U.S. with the Instinct sensor, made by Abbott.
MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor
Price charts implemented using Lightweight Charts™